Efficacy and Safety of Varenicline for Adolescent Smoking Cessation
Open Access
- 1 December 2019
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Pediatrics
- Vol. 173 (12) , 1146-1153
Abstract
Tobacco use is the leading cause of preventable death in the United States and the world.1 Although rates of smoking initiation in adolescence have declined in the last decade, most adult cigarette smokers began smoking before 21 years of age, and almost all adolescents who smoke regularly will continue smoking well into adulthood, leading to a life expectancy at least 10 years shorter than that of nonsmokers.1-4 Almost two-thirds of adolescent smokers are interested in quitting, but only 4% to 6% of unassisted quit attempts are successful.3-6Keywords
This publication has 41 references indexed in Scilit:
- Varenicline versus Bupropion XL for Smoking Cessation in Older Adolescents: A Randomized, Double-Blind Pilot TrialNicotine & Tobacco Research, 2011
- Comorbid psychiatric disorders and nicotine dependence in adolescenceAddiction, 2011
- Bupropion SR and contingency management for adolescent smoking cessationJournal of Substance Abuse Treatment, 2011
- Varenicline in prevention of relapse to smoking: effect of quit pattern on response to extended treatmentAddiction, 2009
- Pharmacokinetics, safety, and tolerability of varenicline in healthy adolescent smokers: A multicenter, randomized, double-blind, placebo-controlled, parallel-group studyClinical Therapeutics, 2009
- A Randomized Trial of Nicotine Nasal Spray in Adolescent SmokersPediatrics, 2008
- Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trialThorax, 2008
- Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trialsCanadian Medical Association Journal, 2008
- Nicotine dependence, withdrawal symptoms, and adolescents' readiness to quit smokingNicotine & Tobacco Research, 2001
- Do adolescent smokers experience withdrawal effects when deprived of nicotine?Experimental and Clinical Psychopharmacology, 2001